At BIOMEDIQA, our commitment to continuous innovation is unwavering. We work tirelessly to meet today’s needs and anticipate those of tomorrow. It’s with great excitement that we unveil our latest feature for our DOSITRACE DACS: skin dose mapping.
This revolutionary new function is a major asset for accurately assessing the radiological risks involved in every medical procedure. But that’s not all: we go even further. A major breakthrough is currently under development: 3D cartography.
After meticulous trials and tests, our DACS now incorporates both male and female mannequins, covering a wide range of body types, based on Body Mass Index (BMI). Our dedicated team works diligently to ensure that the dose is accurately projected onto the patient, guaranteeing optimum precision.
Are you curious to learn more about these new products, or do you have any questions?
Please don’t hesitate to contact us if you have any questions. commercial@biomediqa.com or communication@biomediqa.com, we look forward to hearing from you.
